Skip to main content
Advertisement
Advertisement

KPRX

KPRX logo

Kiora Pharmaceuticals, Inc. Common Stock

2.67
USD
Sponsored
+0.05
+1.91%
Sep 24, 15:56 UTC -4
Closed
exchange

Pre-Market

2.63

-0.04
-1.31%

KPRX Earnings Reports

Positive Surprise Ratio

KPRX beat 26 of 41 last estimates.

63%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.38
Implied change from Q2 26 (Revenue/ EPS)
--
/
+11.76%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-3900.00%

Kiora Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 07, 2026, KPRX reported earnings of -0.34 USD per share (EPS) for Q2 26, beating the estimate of -0.63 USD, resulting in a 46.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.38 USD, with revenue projected to reach -- USD, implying an increase of 11.76% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Kiora Pharmaceuticals, Inc. Common Stock reported EPS of -$0.34, beating estimates by 46.24%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 3 analysts, Kiora Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.38 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement